Healthcare
Neuberger exits Service Med to MedicAir
GP sells its 75% stake in the medical company, controlled via Atlante Private Equity Fund
Abénex backs medical imaging software provider EDL
GP plans to support the company in boosting its organic growth and accelerating its expansion through targeted add-ons
Paragon’s Apontis Pharma completes IPO
GP acquired the single-pill producer in a carve-out in 2018 and will retain a 31% stake
UI Investissement, Geneo back clinic operator GBNA
UI and Geneo invest in the company via a capital increase, partnering with the Guichard family
Abingworth Clinical Co-Development Fund 2 closes on $582m
ACCD 2 finances the development of late-stage clinical programmes of pharmaceutical and biotechnology companies
Gilde Healthcare buys majority stake in Klifo
Gilde Healthcare has now made five investments from its Gilde Healthcare Services III fund
Andera Partners lines up DACH expansion plans
Starting with BioDiscovery 6, the GP intends to accelerate fundraising and deal-making in the region
NeoGenomics buys VC-backed Inivata for $390m
Inivata will become a separate business division alongside NeoGenomics' clinical, pharma and informatics units
Gimv increases stake in GPNZ
Gimv has increased the size of the majority stake that it already held in the dental chain
Paragon-backed Apontis Pharma sets IPO price range
Shares are priced at €18.5-24.5, with a final pricing expected on 6 May before the 11 May listing
VCs in $75m round for Kaia Health
Digital physical therapy platform is backed by all existing investors, including Balderton Capital
Novo Seeds, Ysios Capital lead €51m round for Adcendo
RA Capital Management, HealthCap and Gilde Healthcare also take part in the round for the biotech startup
Softbank leads $225m series-D round for Exscientia
Japanese investor provided additional $300m equity commitment that can be drawn at the company's discretion
Gilde Healthcare buys Acti-Med
Deal is the fourth platform investment from the GP's €200m Gilde Healthcare Services III fund
CPPIB, Fidelity lead €262m series-D round for Kry
Company was founded six years ago and has so far raised nearly €500m over five rounds
Ardian sells Lagarrigue to Naxicap
Sale ends a five-year holding period for Ardian, which bought a majority stake in Lagarrigue from Azulis Capital
SHS sells stake in Medigroba to trade
Medical homecare provider Medigroba received significant inbound interest from strategic buyers
Endeavour Vision closes Medtech Growth II on $375m
Fund is 30% larger than its predecessor and will continue to focus on medtech growth investments
Paragon-backed Apontis Pharma announces IPO intention
Paragon acquired the pharmaceutical business from its parent company UCB in 2018 via Paragon II
Forbion Growth Opportunities I holds €360m final close
Strategy will target later-stage life sciences businesses, as well as undervalued listed companies
PE-backed diagnostics firm Synlab announces IPO pricing
Shares will be priced at €18-23, equating to a €4-5bn market capitalisation and €5.9-6.9bn EV
Brightlands Venture Partners IV holds €45m first close
Fund invests in renewable chemistry, regenerative medicine and agri-food across the Netherlands, Belgium and parts of Germany
Gimv acquires homecare service Apraxon
GP plans to support the at-home wound care specialist through organic growth and a buy-and-build strategy
VCs in $115m round for CeQur
Funding round is the largest ever recorded for a medical equipment company in Switzerland
